COVID-19 preclinical drug development database
Screening of Targeted Compounds - CVR
University of Glasgow Centre for Virus Research
Added 15/05/2020 | Updated 13/10/2021
Project Details
Type of project
- Tier 1: repurposing existing medicines
- Tier 2: testing existing molecules
- Supporting technologies, models and assays
Therapeutic target
- Preventing infection (prophylaxis or preventing cell entry)
- Preventing virus replication in early disease
- Direct acting antiviral
Type of supporting technology
- Purified SARS-CoV-2 proteins
- Engineered cells lines
- Viral isolates
- Assays and protocols (eg. for virus detection)
Phase of project
- Focused compound screening (eg. known antiviral compounds)
Modality (if can be disclosed)*
- Small molecule
Molecular/cellular target (if known or can be disclosed)*
- Multiple Viral and Host Targets
Partner institutions/organisations
- University of Dundee Drug Discovery Unit
- Bill & Melinda Gates Foundation COVID-19 Therapeutics Accelerator
Key contact
Name: Sam J Wilson
Email Address: sam.wilson@glasgow.ac.uk
Phone Number:
Key Collaborators:
Anticipated timeframe of future outputs
6-12 months
Further Details
Abstract or additional information (if available)*
Published outputs (if available)*
Relevant weblinks
Similar Projects
Project Name
Lead institution
